InChI=1S/C18H30O7/c1-11(19)3-2-4-12(20)5-7-14-15(17(23)10-16(14)22)9-13(21)6-8-18(24)25/h5,7,11-12,14-17,19-20,22-23H,2-4,6,8-10H2,1H3,(H,24,25)/b7-5+/t11?,12-,14+,15+,16+,17-/m0/s1 |
CCDLUYBTWPYEFY-VKOLDSHFSA-N |
CC(O)CCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(=O)CCC(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
View more via ChEBI Ontology
(13E,15S)-9α,11α,15,19-tetrahydroxy-2,3-dinor-6-oxoprost-13-en-1-oic acid
|
5-{(1R,2R,3R,5S)-2-[(1E,3S)-3,7-dihydroxyoct-1-en-1-yl]-3,5-dihydroxycyclopentyl}-4-oxopentanoic acid
|
19-hydroxy-2,3-dinor-6-keto-prostaglandin F1α
|
ChEBI
|
19-hydroxy-2,3-dinor-6-oxo-PGF1α
|
ChEBI
|
19-hydroxy-2,3-dinor-6-oxo-prostaglandin F1α
|
ChEBI
|
19-hydroxy-6-keto-2,3-dinor-prostaglandin F1α
|
ChEBI
|
2,3-dinor-6-keto-19-hydroxy-prostaglandin F1α
|
ChEBI
|
2,3-dinor-6-oxo-19-hydroxy-prostaglandin F1α
|
ChEBI
|
|